Association of postoperative opioid type with mortality and readmission rates: multicentre retrospective cohort study
BJS Open · 2024
DOI: 10.1093/bjsopen/zrae113 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJS Open, 2024. Verfasst von Stasia Winther und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Patient Readmission, Analgesics, Opioid, Postoperative Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Foundation.
Abstract (Originalsprache)
Background
Opioid treatment in postoperative pain management is crucial, but the impact of administration practices on outcomes is unclear. The hypothesis was that prescription trends remained stable over recent years, and that no difference in mortality and readmission risks is associated with prescription strategies.
Method
Electronic health records of surgical episodes in the Capital and Zealand Regions of Denmark from 2017 to 2021 were analysed. All opioids administered during postoperative admission were converted to oral morphine equivalents (OMEQs) and an average daily dose per patient was calculated. The opioid administered in the highest OMEQ dosages is considered the primary opioid strategy for the surgical case. Administration trends were analysed through linear regression, and Cox regression was used to calculate hazard ratios to assess dominant opioid strategies’ association with 90-day mortality and readmission rates while controlling for confounders.
Results
A total of 183 317 patients met the inclusion criteria. Prescription trends remained steady during the study period. Multivariable analysis revealed increased readmission risk (HR 1.18, P < 0.001) of tramadol and tapentadol compared to morphine. They exhibited decreased 90-day mortality risk (HR 0.63, P < 0.001). Oxycodone had similar readmission risk (HR 1.009, P = 0.24) but lower 90-day mortality risk (HR 0.68, P < 0.001).
Conclusion
Postoperative in-hospital opioid administration remained stable from 2017 to 2021. Tramadol/tapentadol had a higher risk of readmission but lower mortality risk. Oxycodone had comparable readmission but reduced mortality risk. This study provides a framework for future clinical trials assessing this potential impact of opioids in a targeted manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Center for Surgical Translational and Artificial Intelligence Research (CSTAR), Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Pharmacology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Martin Sillesen
Förderung
- Novo Nordisk Foundation
Zitieren
APA
Winther, S., Jimenez-Solem, E., & Sillesen, M. (2024). Association of postoperative opioid type with mortality and readmission rates: multicentre retrospective cohort study. BJS Open. https://doi.org/10.1093/bjsopen/zrae113
Vancouver
Winther S, Jimenez-Solem E, Sillesen M. Association of postoperative opioid type with mortality and readmission rates: multicentre retrospective cohort study. BJS Open. 2024. doi:10.1093/bjsopen/zrae113
BibTeX
@article{Winther2024,
author = {Winther, Stasia and Jimenez-Solem, Espen and Sillesen, Martin},
title = {Association of postoperative opioid type with mortality and readmission rates: multicentre retrospective cohort study},
journal = {BJS Open},
year = {2024},
doi = {10.1093/bjsopen/zrae113}
}
EUVIMED